New Report "Rx to OTC Switches 2009 " available through Aarkstore Enterprise
09/25/2009

The report covers OTC drugs that were once only available by prescription due to either the active ingredient or dosage of the drug.

Online PR News – 25-September-2009 – – The U.S. market for Rx-to-OTC Switches encompasses a wide variety of products that have been determined safe and effective as over-the-counter products. The market is fueled by several factors including an aging population; steady to increased incidences of conditions and diseases; new drug classes switched to OTC; product demand; economic conditions and several other factors.

All product areas contribute to the growth and development of the OTC market; however, new product development and additional regulatory review and approval of new OTC drug classifications, specifically in areas such as gastrointestinal drugs, cholesterol-reducing drugs, and contraceptives are expected to make the most impact for continued growth.

As part of its coverage, this report includes

Current Market for Rx to OTC across major categories
Past Results of OTC Switches
Products Most Likely to Switch to OTC
Assessment of the Economic Downturn's Impact
The U.S. Market for Rx-to-OTC Switches focuses on several treatment segments in which Rx-to-OTC switches are available. These include:

Allergy, Cough, Cold, and Sinus Products
Analgesics, NSAIDs, and Pain Treatments
Anti-Infectives
Gastrointestinal Drugs
Hair Loss Products
Hormones
Oral Care
Rectal Ointments
Sleep-aids
Smoking Cessation
Weight Loss
In addition to the areas with switches in place, Kalorama Information has identified other areas which may be open to Rx-to-OTC switches in the future. These include:

Cholesterol-reducing Drugs
Osteoporosis Treatments
Overactive Bladder
Sexual Dysfunction

For more information, please visit :
http://www.aarkstore.com/reports/Rx-to-OTC-Switches-2009-13474.html
Or email us at press@aarkstore.com or call +919272852585

visit our website